Myocardial infarction: redefined or reinvented?
Open Access
- 1 July 2002
- Vol. 88 (1) , 1-3
- https://doi.org/10.1136/heart.88.1.1
Abstract
Troponins have recently been promoted to playing a pivotal role in the diagnosis of acute myocardial infarction. However, a number of problems arise as a result of this “redefinition” of acute MI The recent joint statement by the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) proposing a “redefinition” of myocardial infarction has aroused much interest but also sparked considerable controversy.1 The basis of the new definition is the promotion of troponins to a pivotal role in the diagnosis of acute myocardial infarction, coupled with the relegation of creatine kinase (CK-MB) to a secondary role; and, in the case of total CK, to the realms of history. Elevation of troponins to centre stage in the drama of acute myocardial infarction is a direct consequence of the recent emergence of new terminology for acute coronary disease. Thus the term “acute coronary syndromes”, coined to describe unstable angina and non-Q wave myocardial infarction, now also includes acute Q wave myocardial infarction. This has stimulated the formulation of management strategies based, at the time of presentation, on the ECG and, subsequently, on the biochemical detection of biomarkers, especially troponins. Thus patients with ST segment elevation myocardial infarction (STEMI) are candidates for thrombolysis while those without are considered to have suspected acute coronary syndromes. Those with typical ST-T changes of ischaemia are treated with low molecular heparin, aspirin, and a β blocker. Those with less typical histories and no acute ECG changes can be observed. It is at this point that measurement of troponins has its greatest value for, if positive at 12 hours after the onset of symptoms, a diagnosis of non-ST segment myocardial infarction (non-STEMI) can be made. Those with normal troponin values, but otherwise considered clinically to have acute ischaemia, are classified as unstable angina while …Keywords
This publication has 10 references indexed in Scilit:
- Acute coronary syndrome without ST elevation: implementation of new guidelinesThe Lancet, 2001
- Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevationHeart, 2001
- CONGENITAL HEART DISEASE: Haemodynamic calculations in the catheter laboratoryHeart, 2001
- Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2000
- It’s Time for a Change to a Troponin StandardCirculation, 2000
- Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology Recommendations of the Task Force of the European Society of CardiologyEuropean Heart Journal, 2000
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)Published by Elsevier ,2000
- National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery DiseasesClinical Chemistry, 1999
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- The Prognostic Value of Serum Troponin T in Unstable AnginaNew England Journal of Medicine, 1992